Abstract
Disease modification and structural neuroprotection have been the holy grail for Parkinson's disease (PD) experimental therapeutics. Theoretically, there are a number of ways to implement such therapeutics, but to date all have failed. This review examines the potential of axonal regeneration and trophic factor delivery for the nigrostriatal system as 2 such approaches that historically have initiated much excitement.
Original language | English (US) |
---|---|
Pages (from-to) | 678-683 |
Number of pages | 6 |
Journal | Movement Disorders |
Volume | 33 |
Issue number | 5 |
DOIs | |
State | Published - May 2018 |
Externally published | Yes |
Keywords
- Disease modification
- Trophic Factors
- axons
ASJC Scopus subject areas
- Neurology
- Clinical Neurology